PSMB9 and Cerebral ischemia: Inhibition of immunoproteasome LMP2 promotes angiogenesis and enhances HIF-1α accumulation in a rat model of cerebral ischemia [10], supporting the conclusion that the immunoproteasome possesses proteolytic activity involved in protein degradation.